Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 3, Pages e58051
Publisher
Public Library of Science (PLoS)
Online
2013-03-07
DOI
10.1371/journal.pone.0058051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigallocatechin-3-gallate induces mesothelioma cell deathviaH2O2−dependent T-type Ca2+channel opening
- (2012) Elia Ranzato et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- In Vivo Imaging of Human Malignant Mesothelioma Grown Orthotopically in the Peritoneal Cavity of Nude Mice
- (2012) Mingqian Feng et al. Journal of Cancer
- The Evolution of Multimodality Therapy for Malignant Pleural Mesothelioma
- (2011) Marjorie G. Zauderer et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
- (2011) Michael Graham Espey et al. FREE RADICAL BIOLOGY AND MEDICINE
- Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
- (2011) Derliz Mereles et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Murine Xenograft Model of Spontaneous Metastases of Human Lung Adenocarcinoma
- (2011) James E. Harris et al. JOURNAL OF SURGICAL RESEARCH
- In vitro screening of synergistic ascorbate–drug combinations for the treatment of malignant mesothelioma
- (2011) Simona Martinotti et al. TOXICOLOGY IN VITRO
- Selective Ascorbate Toxicity in Malignant Mesothelioma
- (2010) Elia Ranzato et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro
- (2010) Guang-Xun Li et al. CARCINOGENESIS
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
- (2009) A. Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- Malignant pleural mesothelioma: current treatments and emerging drugs
- (2009) Carmen Belli et al. EXPERT OPINION ON EMERGING DRUGS
- Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects
- (2009) Julien Verrax et al. FREE RADICAL BIOLOGY AND MEDICINE
- Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells
- (2009) Molly Lang et al. LIVER INTERNATIONAL
- Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells
- (2008) Chih-Pin Chuu et al. CANCER LETTERS
- Imatinib Mesylate Enhances Therapeutic Effects of Gemcitabine in Human Malignant Mesothelioma Xenografts
- (2008) P. Bertino et al. CLINICAL CANCER RESEARCH
- Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs
- (2008) Constantina Constantinou et al. INTERNATIONAL JOURNAL OF CANCER
- Survival of pleural malignant mesothelioma in Italy: A population-based study
- (2008) Fabio Montanaro et al. INTERNATIONAL JOURNAL OF CANCER
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
- (2008) Q. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio
- (2008) Shannon Reagan-Shaw et al. PROSTATE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now